Low eligibility for hepatitis B treatment in the Brazilian public health system.
Cristiane Faria Oliveira ScarponiMarco Antônio Ferreira PedrosaMarcos Paulo Gomes MolMichael John Mascarenhas HardmanDirceu Bartolomeu GrecoPublished in: Revista da Sociedade Brasileira de Medicina Tropical (2022)
Few CHB patients were active carriers and eligible candidates for antiviral therapy. This study revealed inadequate pre-treatment conduct in the Brazilian public health system, emphasizing the need for regular laboratory follow-up for patients initially not eligible for treatment. Such information may indirectly subsidize the planning and improvement of actions and services related to optimal HBV management in the public sphere.